Browsing by Subject
Now showing items 1-1 of 1
-
Antitumor Activity of Lurbinectedin, a Selective Inhibitor of Oncogene Transcription, in Patients with Relapsed Ewing Sarcoma: Results of a Basket Phase II Study
(American Association for Cancer Research, 2022-07-01)